Status:
COMPLETED
Geriatric-oncological Study on Quality of Life and Independence After Radiotherapy
Lead Sponsor:
University Hospital Heidelberg
Conditions:
Cancer
Age <70
Eligibility:
All Genders
75+ years
Brief Summary
Elderly patients \* with multiple comorbidities are underrepresented in most radio-oncology studies. In times of individualized therapy and when weighing up oncological over- or under-therapy, this ob...
Detailed Description
Vulnerable patients with deficits (G8 score \<15 pts) receive a geriatric assessment (Comprehensive geriatric assessment (CGA)) consisting of abbreviated comprehensive geriatric assessment (aCGA), app...
Eligibility Criteria
Inclusion
- Age from 75 years
- G8-Screening \<15Pkt
- Potentially curative radiotherapy
Exclusion
- no written informed consent
- life expectancy\< 6 month
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05187845
Start Date
February 1 2021
End Date
April 1 2022
Last Update
November 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Heidelberg, Radiation Oncology
Heidelberg, Germany, 69120